Veru (VERU) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.30, -5.74% vs the prior close of $2.44.
- Volume 305.40K shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
VERU slides 5.7% to $2.30. Closed at $2.30, -5.74% vs the prior close of $2.44. Day range $2.28–$2.48, opened at $2.41.
VERU daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — VERU slides 5.7% to $2.30
- Closed at $2.30, -5.74% vs the prior close of $2.44. Day range $2.28–$2.48, opened at $2.41.
- Volume was 305.40K shares, 1.2x its 50-day average of 245.10K.
- Price is -9.5% vs its 50-day average ($2.54) and -7.9% vs its 200-day average ($2.50).
- 52-week range $2.05–$7.33; today's close sits at 5% of that range, 68.6% below the 52-week high.
Oct 15, 2026 — VERU jumps 14.6% to $2.44 on 2.1x normal volume
- Closed at $2.44, +14.55% vs the prior close of $2.13. Day range $2.12–$2.48, opened at $2.14.
- Volume was 505.30K shares, 2.1x its 50-day average of 236.79K — unusually heavy trading.
- Price is -4.0% vs its 50-day average ($2.54) and -2.3% vs its 200-day average ($2.50).
- 52-week range $2.05–$7.33; today's close sits at 7% of that range, 66.7% below the 52-week high.
Oct 14, 2026 — VERU dips 2.7% to $2.13, a 3-month low, 3 down days in a row
- Closed at $2.13, -2.74% vs the prior close of $2.19. Day range $2.11–$2.29, opened at $2.26.
- Volume was 275.20K shares, 1.2x its 50-day average of 236.41K.
- Price is -16.1% vs its 50-day average ($2.54) and -14.7% vs its 200-day average ($2.50).
- 52-week range $2.05–$7.33; today's close sits at 2% of that range, 70.9% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — VERU slides 9.1% to $2.19, a 3-month low
- Closed at $2.19, -9.13% vs the prior close of $2.41. Day range $2.18–$2.42, opened at $2.41.
- Volume was 169.20K shares, 0.7x its 50-day average of 237.76K.
- Price is -13.9% vs its 50-day average ($2.54) and -12.3% vs its 200-day average ($2.50).
- 52-week range $2.05–$7.33; today's close sits at 3% of that range, 70.1% below the 52-week high.
Oct 12, 2026 — VERU dips 2.0% to $2.41
- Closed at $2.41, -2.03% vs the prior close of $2.46. Day range $2.40–$2.45, opened at $2.44.
- Volume was 85.50K shares, 0.4x its 50-day average of 239.12K — lighter than usual.
- Price is -5.3% vs its 50-day average ($2.54) and -3.5% vs its 200-day average ($2.50).
- 52-week range $2.05–$7.33; today's close sits at 7% of that range, 67.1% below the 52-week high.
Oct 9, 2026 — VERU rises 1.7% to $2.46
- Closed at $2.46, +1.65% vs the prior close of $2.42. Day range $2.42–$2.49, opened at $2.42.
- Volume was 128.90K shares, 0.5x its 50-day average of 239.19K — lighter than usual.
- Price is -3.2% vs its 50-day average ($2.54) and -1.5% vs its 200-day average ($2.50).
- 52-week range $2.05–$7.33; today's close sits at 8% of that range, 66.4% below the 52-week high.
Oct 8, 2026 — VERU dips 1.6% to $2.42, 3 down days in a row
- Closed at $2.42, -1.63% vs the prior close of $2.46. Day range $2.39–$2.52, opened at $2.44.
- Volume was 147.60K shares, 0.6x its 50-day average of 240.16K.
- Price is -4.6% vs its 50-day average ($2.54) and -3.1% vs its 200-day average ($2.50).
- 52-week range $2.05–$7.33; today's close sits at 7% of that range, 67.0% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — VERU dips 0.4% to $2.46
- Closed at $2.46, -0.40% vs the prior close of $2.47. Day range $2.41–$2.54, opened at $2.42.
- Volume was 202.40K shares, 0.8x its 50-day average of 240.07K.
- Price is -2.9% vs its 50-day average ($2.53) and -1.5% vs its 200-day average ($2.50).
- 52-week range $2.05–$7.33; today's close sits at 8% of that range, 66.4% below the 52-week high.
Oct 6, 2026 — VERU slides 3.1% to $2.47 on 6.9x normal volume
- Closed at $2.47, -3.14% vs the prior close of $2.55. Day range $2.44–$2.75, opened at $2.54.
- Volume was 1.52M shares, 6.9x its 50-day average of 219.20K — unusually heavy trading.
- Price is -2.3% vs its 50-day average ($2.53) and -1.0% vs its 200-day average ($2.50).
- 52-week range $2.05–$7.33; today's close sits at 8% of that range, 66.3% below the 52-week high.
Oct 5, 2026 — VERU rises 1.6% to $2.55
- Closed at $2.55, +1.59% vs the prior close of $2.51. Day range $2.50–$2.62, opened at $2.51.
- Volume was 88.60K shares, 0.4x its 50-day average of 219.46K — lighter than usual.
- Price is +1.0% vs its 50-day average ($2.52) and +2.2% vs its 200-day average ($2.49).
- 52-week range $2.05–$7.33; today's close sits at 9% of that range, 65.2% below the 52-week high.
Oct 2, 2026 — VERU dips 1.2% to $2.51
- Closed at $2.51, -1.18% vs the prior close of $2.54. Day range $2.50–$2.56, opened at $2.56.
- Volume was 104.90K shares, 0.5x its 50-day average of 223.05K — lighter than usual.
- Price is -0.3% vs its 50-day average ($2.52) and +0.7% vs its 200-day average ($2.49).
- 52-week range $2.05–$7.33; today's close sits at 9% of that range, 65.8% below the 52-week high.
VERU latest news & SEC filings
Every SEC filing by or about VERU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Barnette K Gary bought 1,800 shares at $2.69 (≈$4.84K) on Aug 13, 2026
- Barnette K Gary bought 1,800 shares at $2.69 (≈$4.84K) on Aug 13, 2026
- Barnette K Gary bought 1,800 shares at $2.69 (≈$4.84K) on Aug 13, 2026
- Barnette K Gary bought 1,800 shares at $2.69 (≈$4.84K) on Aug 13, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$6.99M (prior year -$7.33M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.30 (prior year -$0.50) (loss narrowed vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Jul 2, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade VERU
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Feb 11, 2026, Dec 17, 2025. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.12% (largest 14.6%). That is a volatile stock.
- Liquidity: about 224.77K shares (≈$516.97K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.30 vs a range of $2.05–$7.33 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Aug 11, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: K Gary Barnette bought 1,800 shares on Aug 13, 2026.
- Latest filings: 8-K Sep 8, 2026; 10-Q Aug 10, 2026; 8-K Aug 10, 2026.
- Share count: 17.05M shares outstanding (Aug 6, 2026), +16.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
VERU market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.41 | 2.48 | 2.28 | 2.30 | 305.40K |
| Oct 15, 2026 | 2.14 | 2.48 | 2.12 | 2.44 | 505.30K |
| Oct 14, 2026 | 2.26 | 2.29 | 2.11 | 2.13 | 275.20K |
| Oct 13, 2026 | 2.41 | 2.42 | 2.18 | 2.19 | 169.20K |
| Oct 12, 2026 | 2.44 | 2.45 | 2.40 | 2.41 | 85.50K |
| Oct 9, 2026 | 2.42 | 2.49 | 2.42 | 2.46 | 128.90K |
| Oct 8, 2026 | 2.44 | 2.52 | 2.39 | 2.42 | 147.60K |
| Oct 7, 2026 | 2.42 | 2.54 | 2.41 | 2.46 | 202.40K |
| Oct 6, 2026 | 2.54 | 2.75 | 2.44 | 2.47 | 1.52M |
| Oct 5, 2026 | 2.51 | 2.62 | 2.50 | 2.55 | 88.60K |
| Oct 2, 2026 | 2.56 | 2.56 | 2.50 | 2.51 | 104.90K |
| Oct 1, 2026 | 2.65 | 2.65 | 2.53 | 2.54 | 70.70K |
| Sep 30, 2026 | 2.58 | 2.70 | 2.51 | 2.66 | 183.00K |
| Sep 29, 2026 | 2.53 | 2.58 | 2.50 | 2.56 | 33.10K |
| Sep 28, 2026 | 2.52 | 2.57 | 2.51 | 2.53 | 101.30K |
| Sep 25, 2026 | 2.55 | 2.57 | 2.50 | 2.54 | 115.80K |
| Sep 24, 2026 | 2.42 | 2.52 | 2.42 | 2.51 | 87.40K |
| Sep 23, 2026 | 2.49 | 2.51 | 2.43 | 2.46 | 94.00K |
| Sep 22, 2026 | 2.46 | 2.52 | 2.42 | 2.50 | 121.40K |
| Sep 21, 2026 | 2.44 | 2.49 | 2.43 | 2.44 | 158.20K |
About Veru
Veru (VERU) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MIAMI, FL. State of incorporation: WI. Fiscal year ends September 30. SEC CIK 863894.
VERU board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Harry Fisch | Chief Corporate Officer | May 6, 2026 |
| Grace Hyun | Director | May 6, 2026 |
| Loren Mark Katzovitz | Director | May 6, 2026 |
| Lucy Lu | Director | May 6, 2026 |
| Michael L Rankowitz | Director | May 6, 2026 |
| Mitchell Shuster Steiner | President and CEO | May 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| K Gary Barnette | Chief Scientific Officer | Aug 17, 2026 |
| Harry Fisch | Chief Corporate Officer | May 6, 2026 |
| Michele Greco | Chief Admin Officer and CFO | May 6, 2026 |
| Mitchell Shuster Steiner | President and CEO | May 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 13, 2026 | K Gary Barnette | Buy | 1,800 | $2.69 |
| Aug 13, 2026 | K Gary Barnette | Buy | 1,800 | $2.69 |
| Aug 13, 2026 | K Gary Barnette | Buy | 1,800 | $2.69 |
| Aug 13, 2026 | K Gary Barnette | Buy | 1,800 | $2.69 |
VERU financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 30, 2025 | — | $-22.73M | — | $-30.04M |
| Sep 30, 2024 | $16.89M | $-37.80M | — | $-21.68M |
| Sep 30, 2023 | $16.30M | $-93.15M | -1.10 | $-88.01M |
| Sep 30, 2022 | $39.35M | $-83.78M | -1.05 | $-47.51M |
| Sep 30, 2021 | $61.26M | $7.39M | 0.09 | $-15.57M |
Latest balance sheet: total assets $37.03M, total liabilities $8.65M, cash $23.88M (as of Jun 30, 2026).
VERU earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $2.77 |
| May 13, 2026 | 8-K Item 2.02 (results) | $2.26 |
| Feb 11, 2026 | 8-K Item 2.02 (results) | $2.30 |
| Dec 17, 2025 | 8-K Item 2.02 (results) | $2.23 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $3.17 |
| May 8, 2025 | 8-K Item 2.02 (results) | $5.20 |
| Feb 13, 2025 | 8-K Item 2.02 (results) | $5.30 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Feb 8, 2024 | 8-K Item 2.02 (results) | — |
| Aug 10, 2023 | 8-K Item 2.02 (results) | — |
| May 11, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on VERU
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.